A few local designers have pivoted to create face masks for local health care workers. Photo courtesy of Magpies & Peacocks

The coronavirus is sweeping the globe and creating new challenges. Notably, companies are not able to keep up with the demand for the N95 masks needed to keep the health care workers safe. Now, Houston's fashion industry is stepping up.

Megan Eddings, founder of Accel Lifestyle, says an article she read about the Centers for Disease Control and Prevention (CDC) advising health care professionals to wear homemade masks or bandanas due to the shortage of the N95 masks inspired her. She was compelled to help combat the COVID-19 pandemic locally and nationwide.

"Accel's Prema fabric was created to prevent the growth of bacteria," Eddings tells CultureMap. "The fabric can be washed up to 100 times and it will still be 99.99-percent anti-bacteria."

Eddings says it dawned on her that she has over 500 shirts made, here in Houston, that could easily be recreated into masks. Her supply chain team consists of 20 sewers and she notes that number can quickly double.

"We have enough supplies here to make 9,000 masks and I have 2,800 yards of fabric sitting at my factory in California," she says. "That's enough fabric to make more than 100,000 masks."

Eddings and her team also tell CultureMap that 47,000 yards of elastic is en route to the Bayou City this week.

"I knew this was serious when the president of MD Anderson responded to my Saturday morning email within three minutes of sending," she says. "He's interested, and they want the infection control team to analyze the fabric."

Other local hospitals interested in Accel Lifestyle's masks are Methodist, Texas Children's, Baylor, and Memorial Hermann. The Memorial Sloan Kettering Cancer Center in New York City has also shown interest as well as Yale's New Haven Hospital in New Haven, Connecticut.

Accel's masks are made out of their specialty anti-bacteria fabric. Photo courtesy of Accel

When Chloe Dao made the decision to temporarily close her Rice Village boutique last Tuesday, offering shopping requests by appointment only, she posted a video to her Instagram account the following day about the emotional roller coaster she's been on surrounding the COVID-19 outbreak.

In the video, Dao says she wanted to play a role in helping her community by creating a pattern and hand sewing 100 washable face masks with pockets. She noted in the caption that the pocket allows for extra filtration but that because it's a fabric mask, it does not stop the spread of the virus. Dao also recommends washing the mask before wearing it.

With production underway since her initial 100 masks, available in small/medium and medium/large, Dao and her team have produced close to 1,000 masks for Houstonians who reached out via social media.

"The requests are overwhelming," a representative for the label tells CultureMap. "We're now shifting our focus to help those on the front line of the coronavirus outbreak; the doctors, nurses, family members of doctors and nurses."

For those who would like to donate to Dao's efforts to continue producing these washable masks, click here.

Houston-based, internationally recognized nonprofit design house, Magpies & Peacocks, and Inclán Studio, a local women's ready-to-wear fashion label, are upcycling together to create nonwoven polypropylene masks, which will be distributed to Houston-area hospitals.

Founder and CEO, Sarah-Jayne Smith and vice president and director of communications/PR, Ahshia Berry, tells CultureMap that partnering together was never a question for either of our brands but more "how can we pull our resources together and help during these trying times."

Clarence Lee, a designer at Inclán Studio, tells CultureMap he searched the studio to find elastic cording that didn't get used in past collections.

"Waste as a resource and upcycling material for good use has never been more important than it is right now," Magpies & Peacocks writes on an Instagram post.

Houston Arts Alliance and Visit Houston donated excess promotional products and now, are deconstructed to reuse the material for these masks.

"It's actually a spun plastic, not a fabric, so it works effectively as a filter, and is more moisture resistant," Magpies & Peacocks tells CultureMap. "It's more compliant and efficient for the current exposure to the service industry in the midst of the crisis."

Lee, who is also a lead designer for Magpies & Peacocks, and serves as an executive board member for the nation's exclusive nonprofit design house, tells CultureMap that for them, it simply boils down to help in any capacity, especially after seeing what's happening across the country with the shortage of supplies.

He notes that they may not have all the supplies, but they do have the capability and time to sew to help those that are on the frontline, fighting and sacrificing everything they have.

"[Houston] is our home, and we all have a part to play in helping fight this," he says. "The [fashion] industry has a major role, and now is definitely the time to show how valuable it can be."

Magpies & Peacocks and Inclán Studio aim to produce 500-600 masks, and hopefully more, should they come across more materials, Lee tells CultureMap. Seven volunteers are helping to sew these nonwoven polypropylene masks.

------

This article originally ran on CultureMap.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

7+ can't-miss Houston business and innovation events in June 2026

where to be

Editor's note: The FIFA World Cup comes to Houston this month, joined by major energy conferences and a lineup of fan-favorite, recurring events. Here’s what not to miss and how to register. Please note: this article may be updated to add more events.


June 1-4 — CLEANPOWER 2026 Conference and Exhibition

CLEANPOWER unites policymakers, experts, and corporate leaders to solve the challenges that none can solve alone. This must-attend, four-day conference is packed with cutting-edge discussions about wind, solar, storage, and transmission; dealmaking; networking; and fun.

This event begins June 1 at the George R. Brown Convention Center. Register here.

June 2 — Humans of Healthcare

Houston Methodist Center for Innovation will present its quarterly speaker series, Humans of Healthcare. The series will feature a panel of experts who will share about their career paths and discuss the nuances of the health care industry. This month's session will focus on today’s nursing landscape, the industry’s expectations of nurses and what career paths are possible in the field.

The event is Tuesday, June 2, from 5-6:30 p.m. at the Ion. Register here.

June 9 — Greentown Go Make Kickoff

Head to the Ion to celebrate the Greentown Go Make 2026 cohort. The open-innovation program with Shell Catalysts & Technologies and Technip Energies focuses on catalytic solutions for industrial decarbonization and the energy transition. Hear pitches from the founders and network with a select group of startups while enjoying food and drink.

This event is Tuesday, June 9, from 5:30-8 p.m. Register here.

June 9-10 — Texas Brain Economy Summit

The Center for Houston’s Future and UTMB are bringing the Texas Brain Economy Summit back to Houston this summer to continue to position the region as a global leader in brain health. Expect to hear from leaders of global institutions, including the World Economic Forum, U.S. Chamber of Commerce, McKinsey Health Institute, Global Brain Economy Initiative, Davos Alzheimer’s Collaborative, Business Collaborative for Brain Health (UsAgainstAlzheimer’s), Rice University, Memorial Hermann, MD Anderson and many others. Read InnovationMap's full preview of the event here.

This event begins Tuesday, June 9. Purchase tickets here.

June 10 — MIT Future of Healthcare Technology Forum

The MIT Club of South Texas will host an in-person forum to explore how innovation, government and policy are changing the healthcare industry. The event will feature MIT alumni and Houston healthcare leaders, including Dr. Tim Boone, dean of the Texas A&M School of Engineering Medicine; Cynthia Reinhart-King, chair of bioengineering at Rice University; Dr. Tony Lin, CEO and chairman emeritus of Kelsey-Seybold Clinic; and others.

This event is Wednesday, June 10, from 5:15-8:30 p.m. at the TAMU EnMed Building. Register here.

June 11 — Goals & Gigawatts: Houston Energy & Climate Week The Power of & Kickoff Party

Come watch the Mexico City FIFA opening match while celebrating energy and innovation at the Goals & Gigawatts Kickoff Party. The event will feature food, drinks, and a showcase on Houston Energy & Climate Week. Learn what to expect and how to get involved in HECW before closing the night with a DJ and karaoke.

This event is Thursday, June 11, from 1:30-6:30 p.m. Find more information here.

June 16-17 — Energy Projects Conference & Expo

The Energy Projects Conference & Expo (EPC Show) is the largest event in North America for professionals working at the heart of major energy projects. The essential event for engineering, construction, commissioning, operations and maintenance across multiple energy sectors brings together five leading conferences under one roof. Conference subjects span LNG exporting, hydrogen and ammonia, midstream, petrochem and refining, and sustainable aviation fuels.

This event begins June 16 at George R. Brown Convention Center. Register here.

June 25 – NASA Tech Talk

Every fourth Thursday of the month, NASA experts, including longtime engineer Montgomery Goforth, present on technology development challenges NASA’s Johnson Space Center and the larger aerospace community are facing, and how they can be leveraged by Houston’s innovation community. Stick around after for drinks and networking at Second Draught.

This event is Thursday, June 25, from 6-7 p.m. at the Ion. Register here.

Houston researchers report promising first in-human trial for implantable cancer therapy

cancer breakthrough

When it comes to cancer remedies, the treatment can be as challenging for the body as its cause. But what if immunotherapy could be localized? That’s precisely what a Houston team may soon make a reality.

Rice University researchers, in partnership with MD Anderson Cancer Center, recently published their findings from the first in-human trial of an implantable cancer-fighting treatment in the journal Clinical Cancer Research. The paper details testing of AVB-001, encapsulated cells engineered to release interleukin-2 (IL-2)—a naturally occurring signaling protein that boosts immunity—in the peritoneal cavities of 14 patients. The goal is to avoid the toxicity usually experienced with less targeted treatments, as well as find a solution to IL-2s’ abbreviated half-lives.

“Traditional IL-2 therapy has shown potent antitumor activity, but its clinical use has been limited by severe side effects and delivery challenges,” Omid Veiseh, director of the Rice Biotech Launch Pad, professor of bioengineering at Rice and a senior author on the study, said in a press release. “This platform allows us to localize and sustain cytokine exposure directly where tumors reside while minimizing systemic toxicity.”

Serous ovarian carcinoma is especially well-suited to the use of AVB-001 because it tends to spread throughout the abdomen. After a minimally invasive laparoscopic procedure, patients implanted with the cells were noted to tolerate the treatment well. Half of the enrolled patients’ cancer was stabilized, with several among them reporting extended signs of benefit. No maximum tolerated dose was reached and there were no life-threatening events tied to the study.

If that sounds like less-than-earth-shaking results, this is only the beginning. The capsules were implanted for about one week because IL-2 activity drops off after that. The researchers now know that further testing should include either higher levels, repeated doses, or a combination thereof, in order to create stronger advances.

The team has already made early headway on this next step. Preclinical studies in nonhuman primates were not only tolerated well, but without added toxicity, the apes had consistent pharmacological effects.

“This is a foundational step,” Veiseh explained. “We now have evidence that the platform is safe, biologically active and potentially scalable. The next phase is optimizing dosing and exploring combination therapies to unlock its full clinical potential.”

The combination would also include a checkpoint inhibitor, which might improve AVB-001’s tumor-fighting power. “What is exciting is that we are not just delivering a drug, we are programming a microenvironment,” added Dr. Amir Jazaeri, professor of gynecologic oncology at MD Anderson, member of the Rice Biotech Launch Pad’s clinical advisory board and a senior author on the study. “This opens the door to combination strategies that could amplify immune responses in ways that have not been feasible before.”